ArticleFrontiers in endocrinology2021

Growth Hormone Cotreatment for Low-Prognosis Patients According to the POSEIDON Criteria.

Xueying Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.